![](/img/cover-not-exists.png)
When Metformin Is Not Enough: Pros and Cons of SGLT2 and DPP-4 Inhibitors as a Second Line Therapy
Avogaro, Angelo, Delgado, Elías, Lingvay, IldikoLanguage:
english
Journal:
Diabetes/Metabolism Research and Reviews
DOI:
10.1002/dmrr.2981
Date:
January, 2018
File:
PDF, 886 KB
english, 2018